Citation Tools

Original research
Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids

Download to a citation manager

Cite this article as:
Burri E, Mangana J, Cheng PF, et al
Infliximab in steroid-refractory immune-related hepatitis does not demonstrate hepatotoxicity and may shorten time on steroids